 | Medical glossary. |
S S S- S0 S1 S2 S3 S4 S5 S6 S7 S8 S9 SA SB SC SD SE SF SG SH SI SJ SK SL SM SN SO SP SQ SR SS ST SU SV SW SY
| selected terms: 68 | page 1 of 1 |
- S-Pack
- [ ] (UMLS (RXNORM) C0723171) =Organic Chemical; Pharmacologic Substance
- S-Pak DM
- [ ] (UMLS (RXNORM) C1170596) =Organic Chemical; Pharmacologic Substance ;;
- Sp1 Activation Cofactor Gene
- [Sp1 Activation Cofactor Genes encode (at least 9) protein subunits of the CRSP (Cofactor Required for SP1 activation) complex, which, along with TFIID, is required for efficient activation of gene transcription by SP1, a transcription factor that recognizes enhancer sites in target DNA. Many CRSP complex proteins are also components of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins that interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. (NCI) ( NCI )] (UMLS (NCI) C1336035) =Gene or Genome ;;
- Space
- [An empty area; an area set apart or available for use. ( NCI )] (UMLS (NCI) C1883067) =Spatial Concept
- space medicine
- [ ] (UMLS (CSP) C0037743) =Biomedical Occupation or Discipline ;;
- Space Motion Sickness
- [Disorder characterized by nausea, vomiting, and dizziness, possibly in response to vestibular disorientation or fluid shifts associated with space flight. (From Webster's New World Dictionary)(MSH)] (UMLS (NDFRT)) (C0242700) =Disease or Syndrome ;; =Motion sickness;;
- Space of Fontana
- (UMLS (NCI) C0229134) =Body Space or Junction
- Space of Mall
- (UMLS (NCI) C0227532) =Body Space or Junction
- space perception
- [awareness of the spatial properties of objects; includes physical space. ( CSP )] (UMLS (CSP) C0037744) =Mental Process ;; =perception;;
- Spacer
- (UMLS (NCI) C1704737) Spacer Device Component =Medical Device
- SPACER-INHALER
- (UMLS (NDFRT)) (C1611699) SPACER-INHALER PREPARATION;;SPINHALER;;SPINHALER PREPARATION =Pharmacologic Substance =Unclassified Ingredients;;Unclassified Ingredient Preparations
- Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present
- (UMLS (NCI) C1883068) =Finding
- Spacing
- [An intervening interval of space or time. ( NCI )] (UMLS (NCI) C1710137) =Quantitative Concept
- Spacol T/S
- [ ] (UMLS (RXNORM) C1628291) =Organic Chemical; Pharmacologic Substance
- SPAM1
- [This gene plays a role in the modulation of cell adhesion of spermatozoa. ( NCI )] (UMLS (NCI) C1335859) SPAM1 Gene;;Sperm Adhesion Molecule 1 (PH-20 Hyaluronidase, Zona Pellucida Binding) Gene =Gene or Genome ;;
- Span
- [A smoothing parameter. ( NCI )] (UMLS (NCI) C1711300) =Conceptual Entity
- Spaniard
- (UMLS (HL7) C0337817) =Population Group =Hispanic;; =Andalusian;;Asturian;;Castillian;;Catalonian;;Belearic Islander;;Gallego;;Valencian;;Canarian;;Spanish Basque
- Spanidin
- (UMLS (NCI) C1512285) =Organic Chemical; Pharmacologic Substance
- Spanish American Indian
- (UMLS (NCI) C1555087) =Population Group =American Indian;;
- Spanish Basque
- (UMLS (HL7) C1553367) =Population Group =Spaniard;;
- Spanish Peseta
- [Spanish Peseta, monetary currency of Spain ( HL7V3.0 )] (UMLS (HL7) C1555437) =Quantitative Concept =Currency;;
- Spanish-Language Document
- [Document type ( NCI )] (UMLS (NCI) C1519430) =Intellectual Product ;;
- Spantuss HD
- [ ] (UMLS (RXNORM) C0723408) =Organic Chemical; Pharmacologic Substance
- Sparfloxacin
- (UMLS (NCI) C0052585) =Organic Chemical; Antibiotic =[AM900] ANTI-INFECTIVES, OTHER;;Unclassified Ingredients =SPARFLOXACIN 200 MG
- SPARFLOXACIN 200 MG
- (UMLS (NDFRT)) (C0990351) =Clinical Drug =Sparfloxacin;; =SPARFLOXACIN 200 MG Oral (systemic) tablet
- SPARFLOXACIN 200 MG Oral (systemic) tablet
- [ ] (UMLS (RXNORM) C0693762) =Clinical Drug =SPARFLOXACIN 200 MG;;
- sparfloxacin 200 MG Oral Tablet [Zagam Respipac]
- [ ] (UMLS (RXNORM) C0714621) Zagam Respipac 200 MG Oral Tablet =Clinical Drug
- sparfloxacin 200 MG [Zagam Respipac]
- [ ] (UMLS (RXNORM) C1606543) =Clinical Drug
- sparfloxacin 200 MG [Zagam]
- [ ] (UMLS (RXNORM) C1606544) =Clinical Drug
- SPARFLOXACIN 99 %WW
- [ ] (UMLS (RXNORM) C1164432) =Clinical Drug
- sparfloxacin Oral Tablet
- [ ] (UMLS (RXNORM) C1248010) =Clinical Drug
- sparfloxacin Oral Tablet [Zagam Respipac]
- [ ] (UMLS (RXNORM) C1242417) =Clinical Drug
- sparfloxacin Oral Tablet [Zagam]
- [ ] (UMLS (RXNORM) C1242416) =Clinical Drug
- SPARGANOSIS
- [Infection of animals, including fish and man, with a developmental stage of Diphyllobothrium. This stage has recently been referred to as a plerocercoid but the name sparganum has persisted. Therefore, infection of fish or other animals with the plerocercoid larvae is sparganosis. Fish-eating mammals, including man, are the final hosts. ( MSH )] (UMLS (ICD9CM) C0037753) =Disease or Syndrome ;; =DIPHYLLOBOTHRIAS INTEST;;
- Sparine
- (UMLS (NCI) C0033598) =Organic Chemical; Pharmacologic Substance ;;
- Sparingly
- (UMLS (NCI) C1948048) =Qualitative Concept ;;
- Spark
- (UMLS (NCI) C1883069) Spark Associated with Medical Device;; =Phenomenon or Process
- Spark Gap
- (UMLS (NCI) C1710138) Spark Gap Device Component =Manufactured Object
- sparrow
- [The family Passeridae comprised of small, mainly brown and grey seed-eating birds with conical bills. ( MSH )] (UMLS (CSP) C0326937) =Bird
- sparrowpox virus
- [ ] (UMLS (CSP) C0319271) =Virus
- Sparsely Cellular Collagenised Areas Present
- (UMLS (NCI) C1519431) =Finding ;;
- Sparsely Granulated Pituitary Gland Lactotroph Adenoma
- [A prolactin producing pituitary gland adenoma composed of relatively large, chromophobic or slightly acidophilic cells with well developed, abundant endoplasmic reticulum, and many immature secretory granules. Mature secretory granules are sparse. (NCI05) ( NCI )] (UMLS (NCI) C1710139) =Neoplastic Process
- Sparsely Granulated Pituitary Gland Somatotroph Adenoma
- [A growth hormone producing pituitary gland adenoma composed of small, round cells containing fibrous bodies and scarce, small secretory granules. (NCI05) ( NCI )] (UMLS (NCI) C1710140) Sparsely Granulated Somatotroph Adenoma =Neoplastic Process
- sparsomycin
- [An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. ( MSH )] (UMLS (CSP) C0037759) =Organic Chemical; Antibiotic
- sparteine
- [A quinolizidine alkaloid isolated from several FABACEAE including LUPINUS; SPARTIUM; and CYTISUS. It has been used as an oxytocic and an anti-arrhythmia agent. It has also been of interest as an indicator of CYP2D6 genotype. ( MSH )] (UMLS (CSP) C0037760) =Organic Chemical; Pharmacologic Substance
- SPARTEINE 0.1% DROPS
- [ ] (UMLS (RXNORM) C1355748) =Clinical Drug
- SPARTEINE 1MG/ML DROPS
- [ ] (UMLS (RXNORM) C1355747) =Clinical Drug
- Spasdel
- [ ] (UMLS (RXNORM) C1171374) =Organic Chemical; Pharmacologic Substance
- Spasdell
- [ ] (UMLS (RXNORM) C1602301) =Organic Chemical; Pharmacologic Substance
- SPASM OF ACCOMMODATION
- (UMLS (ICD9CM) C0152196) =Disease or Syndrome
- SPASM OF CONJUGATE GAZE
- [ ] (UMLS (ICD9CM) C0155344) =Sign or Symptom
- Spasm of sphincter of Oddi
- (UMLS (ICD9CM) C0152168) =Pathologic Function
- SPASMODIC TORTICOLLIS
- [A twisted neck symptom that is caused by the spasmodic involuntary muscle contractions in the neck region. ( MSH )] (UMLS (ICD9CM) C0152116) =Sign or Symptom ;;
- Spasmolin
- [ ] (UMLS (RXNORM) C0723409) =Organic Chemical; Pharmacologic Substance
- Spasmonal
- [ ] (UMLS (RXNORM) C0592129) =Organic Chemical; Pharmacologic Substance ;;
- Spasmonal Forte
- [ ] (UMLS (RXNORM) C0595711) =Organic Chemical; Pharmacologic Substance
- spasmophemia
- [ ] (UMLS (CSP) C0599492) =Mental or Behavioral Dysfunction
- Spasquid
- [ ] (UMLS (RXNORM) C0723410) =Organic Chemical; Pharmacologic Substance
- SPASTIC ECTROPION
- [ ] (UMLS (ICD9CM) C0155195) =Disease or Syndrome ;;
- SPASTIC ENTROPION
- [ ] (UMLS (ICD9CM) C0155190) =Disease or Syndrome ;;
- Spastic hemiplegia
- [ ] (UMLS (ICD9CM) C0154694) =Sign or Symptom ;;
- Spastic hemiplegia, affecting dominant side
- [ ] (UMLS (ICD9CM) C0375211) =Sign or Symptom
- Spastic hemiplegia, affecting nondominant side
- [ ] (UMLS (ICD9CM) C0375212) =Sign or Symptom
- spastic paralysis
- [paralysis marked by spasticity of the muscles of the paralyzed part and increases tendon reflexes, due to upper motor neuron lesions. ( CSP )] (UMLS (CSP) C0085621) =Pathologic Function =paralysis;;
- spastic pseudosclerosis
- [ ] (UMLS (CSP) C0599464) =Disease or Syndrome
- Spastolate
- [ ] (UMLS (RXNORM) C0723411) =Pharmacologic Substance ;;
- Spastrin
- [ ] (UMLS (RXNORM) C0723412) =Organic Chemical; Pharmacologic Substance
- Spatial Design
- [Refers to the ways in which objects or bodies are placed in space and in relation to each other. ( NCI )] (UMLS (NCI) C0681263) =Intellectual Product ;;
| UMLS | MEDINDEX.AM |
 to main page | About • Catalog. Medical sites. • UMLS.Semantic Types. • Feedback |  top of page |